CytRx Corp. buy melinda
Start price
20.09.17
/
50%
€2.35
Target price
16.02.18
€3.61
Performance (%)
-39.85%
End price
16.02.18
€1.41
Summary
This prediction ended on 16.02.18 with a price of €1.41. Massive losses of -39.85% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CytRx Corp. | - | - | - | - |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % | 53,31 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % | 93,48 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % | 52,32 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % | 66,74 % |
Comments by melinda for this prediction
In the thread CytRx Corp. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$
(Vom Mitglied beendet)